Paracetamol, Pan D, Shelcal and 52 Medicines Fail Quality Tests!
CDSCO has labeled 50 widely-used medicines as "Not of Standard Quality" after they failed quality tests, prompting health alerts.
India's drug regulator, the Central Drugs Standards Control Organisation (CDSCO), has recently released a list of 50 medicines labeled as "Not of Standard Quality (NSQ)" after they failed quality tests at a government drug-testing lab in Kolkata.
The list includes popular medicines like Shelcal (Vitamin C and D3 tablets), Softgels (Vitamin B complex and C), Pan-D (an antacid), Paracetamol IP 500 mg, Glimepiride (for diabetes), Metronidazole (for stomach infections), and BP medicine Telma 40 (Telmisartan).
These medicines are manufactured by leading pharmaceutical companies like Alkem Laboratories, Hindustan Antibiotics Limited (HAL), Pure & Cure Healthcare, Sun Pharma, and Glenmark Pharmaceuticals.
CDSCO issued two lists—one with 48 drugs and another with 5 additional drugs along with responses from their manufacturers. However, the companies denied responsibility for the failed tests, stating that the problematic batches were not made by them and calling for further investigation.
This alert follows CDSCO's ban on 156 fixed-dose drug combinations in August 2024, citing health risks. These included popular painkillers, fever, and allergy medicines.
It is important to stay informed about such drug quality alerts from the government, as they help prevent health risks like adverse reactions, toxicity, or ineffectiveness. Make sure to take such health alerts seriously to protect yourself and your loved ones.
Keep watching ISH News for similar alerts and updates on current affairs.
